To take Nigeria’s healthcare sector to expected level, SYNLAB Nigeria has identified the need for strategic collaboration and investment. Kenneth read more SYNLAB Nigeria seeks collaboration, investment to transform healthcare
SYNLAB Nigeria has emphasized the need for strategic collaboration and investment to transform the country's healthcare sector. Kenneth Okolie, the company's CEO, highlighted that partnerships and coordinated efforts among stakeholders are essential for improving healthcare quality, accessibility, and sustainability. SYNLAB aims to provide world-class medical diagnostics and meet international standards in healthcare delivery. The company also sees potential in Nigeria's medical tourism industry, comparing it to destinations like the UAE and the Caribbean. SYNLAB's vision includes ambitious expansion over the next decade, focusing on bridging healthcare gaps and enhancing service delivery. The company's market dominance is attributed to its commitment to high-quality laboratory services, ethical practices, and obtaining ISO 15189 certification. Richard Ajayi, founder of PathCare Nigeria (now SYNLAB), and Weert Börner, the German consul general in Nigeria, commended the company's contributions to diagnostic services and its German origins.
